GR1008380B - Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου - Google Patents
Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτουInfo
- Publication number
- GR1008380B GR1008380B GR20130100652A GR20130100652A GR1008380B GR 1008380 B GR1008380 B GR 1008380B GR 20130100652 A GR20130100652 A GR 20130100652A GR 20130100652 A GR20130100652 A GR 20130100652A GR 1008380 B GR1008380 B GR 1008380B
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- antiviral agent
- pharmaceutical composition
- relates
- valganciclovir
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αφορά σταθερό φαρμακευτικό σκεύασμα στέρεας φαρμακοτεχνικής μορφής για χορήγηση διά στόματος περιέχον ως δραστική ουσία έναν αντιικό παράγοντα, όπως Βαλγκανσικλοβίρη ή κάποιο φαρμακευτικά αποδεκτό άλας, παράγωγο ή πολύμορφο αυτής. Επίσης, η εφεύρεση αφορά και τη μέθοδο παρασκευής του ως άνω σκευάσματος.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20130100652A GR1008380B (el) | 2013-11-21 | 2013-11-21 | Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20130100652A GR1008380B (el) | 2013-11-21 | 2013-11-21 | Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1008380B true GR1008380B (el) | 2014-12-18 |
Family
ID=52395310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20130100652A GR1008380B (el) | 2013-11-21 | 2013-11-21 | Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Country Status (1)
Country | Link |
---|---|
GR (1) | GR1008380B (el) |
-
2013
- 2013-11-21 GR GR20130100652A patent/GR1008380B/el active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500281A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
PH12018500975A1 (en) | 7-(thiazol-5-yl) pyrrolopyrimidine compound as tlr7 agonist | |
MX2019005379A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
EA033544B1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
PH12017502376B1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
PH12016501519B1 (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
MX2017009289A (es) | Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas. | |
MX2017013099A (es) | Metodos para el tratamiento de trastornos inflamatorios. | |
PH12020550763A1 (en) | Pyridinone derivatives and their use as selective alk-2 inhibitors | |
WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
GR1008228B (el) | Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου | |
EP2722322A4 (en) | 1,3-DI-OXOINDENE DERIVATIVE, ITS OPTICAL ISOMER OR PHARMACEUTICALLY ACCEPTABLE SALT, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ANTIVIRAL ACTIVE INGREDIENT | |
PL420169A1 (pl) | N-Guanylowe pochodne 9-amino-5,11-dimetylo-5H-indolo[2,3-b]chinoliny, sposób ich otrzymywania i zawierające je środki farmaceutyczne | |
GR1008380B (el) | Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου | |
GR1008819B (el) | Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου | |
GR1008169B (el) | Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου | |
ZA201803722B (en) | Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof | |
IN2013MU02366A (el) | ||
IN2014CH00984A (el) | ||
TH132242B (th) | องค์ประกอบทางเภสัชกรรมที่ประกอบด้วยไฮโดรมอร์โฟนและนาล็อกโซน (Pharmaceutical compositions comprising hydromorphone and naloxone) | |
PT3611158T (pt) | Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral | |
GR1007907B (el) | Φαρμακευτικο σκευασμα περιεχον ενα φαινοκαρβαμικο αναστολεα της ακετυλχοληνεστερασης | |
GR1007712B (el) | Φαρμακευτικο σκευασμα περιεχον εναν ανταγωνιστη των υποδοχεων των λευκοτριενων και μεθοδος για την παρασκευη αυτου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20150128 |